全文获取类型
收费全文 | 5920篇 |
免费 | 261篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 83篇 |
妇产科学 | 58篇 |
基础医学 | 948篇 |
口腔科学 | 72篇 |
临床医学 | 383篇 |
内科学 | 1624篇 |
皮肤病学 | 18篇 |
神经病学 | 656篇 |
特种医学 | 194篇 |
外科学 | 822篇 |
综合类 | 26篇 |
预防医学 | 115篇 |
眼科学 | 96篇 |
药学 | 444篇 |
中国医学 | 19篇 |
肿瘤学 | 628篇 |
出版年
2023年 | 26篇 |
2022年 | 54篇 |
2021年 | 139篇 |
2020年 | 57篇 |
2019年 | 86篇 |
2018年 | 111篇 |
2017年 | 84篇 |
2016年 | 112篇 |
2015年 | 131篇 |
2014年 | 156篇 |
2013年 | 233篇 |
2012年 | 348篇 |
2011年 | 409篇 |
2010年 | 249篇 |
2009年 | 202篇 |
2008年 | 372篇 |
2007年 | 409篇 |
2006年 | 419篇 |
2005年 | 356篇 |
2004年 | 368篇 |
2003年 | 377篇 |
2002年 | 382篇 |
2001年 | 63篇 |
2000年 | 50篇 |
1999年 | 87篇 |
1998年 | 101篇 |
1997年 | 92篇 |
1996年 | 80篇 |
1995年 | 60篇 |
1994年 | 89篇 |
1993年 | 64篇 |
1992年 | 57篇 |
1991年 | 51篇 |
1990年 | 29篇 |
1989年 | 36篇 |
1988年 | 34篇 |
1987年 | 22篇 |
1986年 | 27篇 |
1985年 | 34篇 |
1984年 | 31篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 19篇 |
1979年 | 8篇 |
1978年 | 14篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 6篇 |
排序方式: 共有6226条查询结果,搜索用时 15 毫秒
91.
Hiroki Tojima Satoru Kakizaki Takashi Kosone Norio Horiguchi Yuichi Yamazaki Ken Sato Hitoshi Takagi Masatomo Mori 《Hepatology International》2012,6(3):620-630
Background
Hepatocyte growth factor (HGF) is a potent growth factor involved in liver regeneration that has various effects on epithelial and nonepithelial cells. Although it has been demonstrated that HGF can reduce liver inflammation or fibrosis caused by pharmaceutical or chemical insult, no examination of its effect on liver injury in nonalcoholic steatohepatitis (NASH) has been reported. 相似文献92.
Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema 下载免费PDF全文
Masanori Atsukawa Keizo Kato Hiroshi Abe Noritomo Shimada Toru Asano Tadashi Ikegami Mai Koeda Tomomi Okubo Taeang Arai Ai Nakagawa‐Iwashita Yuji Yoshida Korenobu Hayama Norio Itokawa Chisa Kondo Yoshimichi Chuganji Yasushi Matsuzaki Katsuhiko Iwakiri 《Journal of gastroenterology and hepatology》2018,33(6):1256-1263
93.
Yu Seri Norio Hanata Yasuo Nagafuchi Shuji Sumitomo Keishi Fujio 《Modern rheumatology / the Japan Rheumatism Association》2017,27(4):696-698
A 59-year-old man who presented with continuous fever, livedo reticularis, and left leg ischemia with multiple tibial artery stenosis and renal artery aneurysm, as demonstrated by arteriography, was diagnosed with polyarteritis nodosa (PAN) 6 years ago. Although he frequently relapsed in spite of intensive immunosuppressive therapies, the disease activity of PAN was controlled with repeated rituximab (RTX) therapies and steroid doses were tapered safely. Peripheral CD19+ B-cells disappeared soon after the 1st administration of RTX. Although CD19+ B-cells remained absent, 3.1% of CD3+CD20+ T-cells were observed in the peripheral blood prior to the 2nd administration of RTX. Recent studies have suggested the pathogenic role of CD3+CD20+ T-cells in autoimmune diseases in the context of RTX therapy; therefore, their roles in the pathogenesis of PAN also need to be considered. 相似文献
94.
Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis 下载免费PDF全文
Hisako Saito Norio Hanafusa Junko Kishikawa Eisei Noiri Eiji Sunami Soichiro Ishihara Toshiaki Watanabe Masaomi Nangaku 《Journal of clinical apheresis》2016,31(6):584-586
Ulcerative colitis (UC) is a major type of idiopathic inflammatory bowel disease (IBD). Immunosuppressive therapies are used to treat IBD patients. Clinicians have strong concerns about using immunosuppressive therapies for IBD patients with hepatitis B virus (HBV) infection because aggressive immunosuppressive therapy can promote reactivation of HBV. For that reason, physicians hesitate to use steroids or other immunosuppressive drugs for IBD patients with HBV infection. Granulocyte monocyte apheresis (GMA) is a safe and effective therapy for UC patients. In Japan, a maximum of 11 sessions of GMA are allowed for moderate‐to‐severe, steroid‐resistant UC patients. However, the effects of GMA on HBV remain unclear. This case report describes a 39‐year‐old man with active UC complicated by HBV infection. Although his symptoms improved with steroid treatment while under entecavir therapy, clinical remission could not be maintained after the steroid dosage was decreased, so GMA was started. After GMA initiation, the frequency of diarrhea decreased and his symptoms improved, and the steroid dosage could be decreased. During the course of GMA, the patient did not experience deterioration in his hepatitis and the HBV DNA level gradually decreased, although GMA itself did not affect the HBV DNA level during each session of GMA. Results show that GMA is a safe and efficacious strategy against UC complicated by HBV without affecting hepatitis because GMA had no remarkable effect on HBV activity. J. Clin. Apheresis 31:584–586, 2016. © 2015 Wiley Periodicals, Inc. 相似文献
95.
96.
Yasushi Rino Munetaka Masuda Norio Yukawa Hitoshi Murakami Ken Takata Tsutomu Hayashi Shin-ichi Suzuki Kei-ichiro Kasama Toshio Imada 《Esophagus》2010,7(1):71-74
In this report, we describe our traction suture technique of the pericardium for suspension of the heart without hemodynamic
instability to obtain excellent exposure in the abdominal-transhiatal approach (TH). Our technique is an application of deep
pericardium stitches for off-pump coronary artery bypass surgery. In detail, the left hepatic lobe is detached at its triangular
ligament from the diaphragm and is deflected to the right. Then, the tendinous portion of the diaphragm arching over the esophagus
is incised upward in the midline until the pericardium is exposed. Pericardial fatty tissue was dissected. Three U-shaped
sutures reinforced with a felt pledget are placed on the posterior aspect of the pericardium and diaphragm. A 15 Fr. flexible
catheter is placed over both ends of the suture to avoid damage of the adjacent organs. Finally, the sutures are fixed to
the drape of anterior wall of the patient to maintain good exposure. 相似文献
97.
Manabu Hayama Hidekazu Suzuki Takayuki Shiroyama Motohiro Tamiya Norio Okamoto Ayako Tanaka Naoko Morishita Takuji Nishida Takashi Nishihara Tomonori Hirashima 《Journal of thoracic disease》2016,8(1):116-123
Background
Long-term oxygen therapy (LTOT) is sometimes prescribed for patients with advanced lung cancer who are potential candidates for chemotherapy. The aim of this study was to assess the usefulness of chemotherapy for patients with this disease who require LTOT.Methods
The medical records of 40 patients with advanced lung cancer who received LTOT while undergoing systemic chemotherapy at our institution between January 2009 and December 2014 were retrospectively reviewed. Chemotherapy consisted of cytotoxic or molecular-targeted agents.Results
Twenty-four patients had adenocarcinoma, 6 had squamous cell carcinoma, and 10 had small cell lung cancer (SCLC). The median survival time from the date of the first chemotherapy cycle performed in conjunction with LTOT was 194 days. In a multivariate analysis, the only factor significantly associated with better prognosis was the line (first or second) of the first chemotherapy with LTOT (hazard ratio =0.42; 95% confidence interval, 0.18 to 0.94). Among the 40 patients, 10 (25%) received chemotherapy during the last 30 days of their lives, 2 of whom died of chemotherapy-related adverse events.Conclusions
Chemotherapy for patients with advanced lung cancer who receive LTOT may be acceptable if it is the first- or second-line treatment. However, we should be mindful of the potential overuse of chemotherapy and its negative impact on quality of life. 相似文献98.
99.
Mami Hirata Kiyotaka Kurose Hisaka Minami Teru Kumagi S M. Fazle Akbar Koujirou Michitaka Norio Horiike Morikazu Onji 《Alcoholism, clinical and experimental research》2004,28(S2):148S-152S
Background: Low incidence of reversal blood flow at the portal vein has been reported by measurement in larger and extrahepatic blood vessels but not in intrahepatic blood vessels in patients with liver cirrhosis. Moreover, there is little information regarding the incidence of reversal blood on the basis of the cause of liver cirrhosis. The aim of this study was to measure the reversal blood flow in the portal vein including intrahepatic branches in patients with alcoholic and viral cirrhosis.
Methods: The blood flow in the portal vein and existence of portosystemic shunt were studied in 52 and 27 patients with alcoholic and viral cirrhosis, respectively, by Doppler ultrasonography. The parameters of liver function test and the prevalence of ascites and esophageal varices were compared between patients with and without reversal blood flow.
Results: Reversal blood flow at the portal vein was found only in patients with only alcoholic cirrhosis (17 of 52 patients) but not in any patients with viral cirrhosis (0 of 27 patients; p < 0.05). The incidence of portosystemic ascites and red color of esophageal varices was also higher in patients with alcoholic cirrhosis with reversal blood flow in the portal vein compared with patients without reversal blood flow ( p < 0.05).
Conclusions: Reversal blood flow in the portal vein is a characteristic feature of alcoholic cirrhosis. The presence of reversal blood flow indicates severe liver diseases, and this feature may have prognostic importance for patients with alcoholic cirrhosis. 相似文献
Methods: The blood flow in the portal vein and existence of portosystemic shunt were studied in 52 and 27 patients with alcoholic and viral cirrhosis, respectively, by Doppler ultrasonography. The parameters of liver function test and the prevalence of ascites and esophageal varices were compared between patients with and without reversal blood flow.
Results: Reversal blood flow at the portal vein was found only in patients with only alcoholic cirrhosis (17 of 52 patients) but not in any patients with viral cirrhosis (0 of 27 patients; p < 0.05). The incidence of portosystemic ascites and red color of esophageal varices was also higher in patients with alcoholic cirrhosis with reversal blood flow in the portal vein compared with patients without reversal blood flow ( p < 0.05).
Conclusions: Reversal blood flow in the portal vein is a characteristic feature of alcoholic cirrhosis. The presence of reversal blood flow indicates severe liver diseases, and this feature may have prognostic importance for patients with alcoholic cirrhosis. 相似文献
100.
Eiko Hasegawa Masahiro Kobayashi Yusuke Kawamura Hiromi Yatsuji Hitomi Sezaki Tetsuya Hosaka Norio Akuta Fumitaka Suzuki Yoshiyuki Suzuki Yasuji Arase Kenji Ikeda Hiromitsu Kumada 《Hepatology research》2007,37(10):793-800
Background: We assessed the efficacy and anticarcinogenic effects of interferon (IFN) therapy in patients with hepatitis C virus (HCV)-related cirrhosis. Methods: The study subjects were 123 Japanese patients with HCV-related cirrhosis with genotype 1b low viral load or genotype 2 who received IFN from 1989 to 2005 (18 patients continue to receive IFN therapy). They included 81 men and 42 women aged 29-74 years (median, 56 years). Results: Univariate analysis identified four parameters that significantly influenced SVR; viral load (low HCV concentration, P < 0.001), duration of IFN therapy (>/= 52 weeks, P = 0.029), daily dose of IFN (>/= 6 million units, P = 0.018), induction therapy (presence, P = 0.010) and choline esterase (> 1.0 DeltapH, P = 0.037). Multivariate analysis identified viral load (risk ratio = 6.329, P < 0.001) and daily dose of IFN (risk ratio = 2.62, P = 0.042) as two independent parameters thatinfluenced SVR. During the observation period, newly developed hepatocellular carcinoma (HCC) was detected in 22 patients. The rates of development of HCC in patients with SVR were 5.8% at the fifth year and 10.3% at the 10th year, compared with 25.8% at the fifth year and 42.5% at the 10th year in non-SVR patients. Multivariate analysis showed that IFN efficacy (SVR) was the only independent factor of hepatocarcinogenesis (hazard ratio: 0.185, 95% confidence interval: 0.042-0.810, P = 0.025) Conclusion: Among patients with HCV-related cirrhosis, the rate of development of HCC is significantly less in patients with SVR. 相似文献